The pharmacology of basal forebrain involvement in cognition.
Chrobak
J J
JJ
Department of Pharmacology and Experimental Therapeutics, Loyola University Chicago, Stritch School of Medicine Maywood, IL.
Napier
T C
TC
Hanin
I
I
Walsh
T J
TJ
D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D001388:Aziridines / Q000008:administration & dosage / Q000494:pharmacology; D001640:Bicuculline / Q000494:pharmacology; D002552:Cerebral Ventricles / Q000187:drug effects / Q000502:physiology; D002794:Choline / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology; D003071:Cognition / Q000187:drug effects / Q000502:physiology*; D009118:Muscimol / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D009498:Neurotoxins / Q000494:pharmacology*; D016548:Prosencephalon / Q000033:anatomy & histology / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D013373:Substance P / Q000494:pharmacology; D001615:beta-Endorphin / Q000494:pharmacology
D001388:Aziridines; D009498:Neurotoxins; D009118:Muscimol; D013373:Substance P; D009270:Naloxone; D001615:beta-Endorphin; C044894:ethylcholine aziridinium; D002794:Choline; D001640:Bicuculline